This inventor holds 1 USPTO granted patent. Top assignee: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Innovations of Xiaoping Jin in Therapeutic Combinations
Introduction
Xiaoping Jin is a notable inventor based in Zhongshan, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of therapeutic combinations that target various tumors. His innovative work has the potential to impact cancer treatment positively.
Latest Patents
Xiaoping Jin holds a patent for a therapeutic combination of a quinoline derivative and an antibody. This patent includes an immune checkpoint inhibitor and a tyrosine kinase inhibitor, where the tyrosine kinase inhibitor is a compound of a specific formula or a pharmaceutically acceptable salt thereof. The therapeutic combination demonstrates promising activity against lung tumors and liver tumors, showcasing its potential effectiveness in cancer therapy.
Career Highlights
Xiaoping Jin is associated with Chia Tai Tianqing Pharmaceutical Group Co., Ltd., a leading pharmaceutical company in China. His work at this organization has allowed him to focus on innovative research and development in the pharmaceutical sector. His dedication to advancing medical science is evident through his patent and ongoing research efforts.
Collaborations
Xiaoping Jin collaborates with Chen Shen, a talented female coworker, who contributes to the research and development processes within their team. Their partnership exemplifies the collaborative spirit necessary for innovation in the pharmaceutical industry.
Conclusion
Xiaoping Jin's contributions to therapeutic combinations represent a significant advancement in cancer treatment. His innovative patent and collaboration with skilled professionals highlight the importance of teamwork in achieving breakthroughs in medical science.